Last Updated: November 5, 2026

LIOTHYRONINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Liothyronine, and what generic alternatives are available?

Liothyronine is a drug marketed by Xgen Pharms, Biocon Pharma, Dr Reddys Labs Sa, Pharmobedient, Sigmapharm Labs Llc, Sun Pharm, Teva Pharms Usa, Watson Labs, and Zydus Lifesciences. and is included in ten NDAs.

The generic ingredient in LIOTHYRONINE is liothyronine sodium. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the liothyronine sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Liothyronine

A generic version of LIOTHYRONINE was approved as liothyronine sodium by XGEN PHARMS on August 17th, 2005.

  Start Trial

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for LIOTHYRONINE?
  • What are the global sales for LIOTHYRONINE?
  • What is Average Wholesale Price for LIOTHYRONINE?
Summary for LIOTHYRONINE
US Patents:0
Applicants:9
NDAs:10
Drug Prices: Drug price information for LIOTHYRONINE
Drug Sales Revenues: Drug sales revenues for LIOTHYRONINE
DailyMed Link:LIOTHYRONINE at DailyMed
Drug patent expirations by year for LIOTHYRONINE
Drug Prices for LIOTHYRONINE

See drug prices for LIOTHYRONINE

Drug Sales Revenue Trends for LIOTHYRONINE

See drug sales revenues for LIOTHYRONINE

US Patents and Regulatory Information for LIOTHYRONINE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xgen Pharms LIOTHYRONINE SODIUM liothyronine sodium INJECTABLE;INJECTION 076923-001 Aug 17, 2005 RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Teva Pharms Usa LIOTHYRONINE SODIUM liothyronine sodium TABLET;ORAL 211510-002 Oct 26, 2018 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Zydus Lifesciences LIOTHYRONINE SODIUM liothyronine sodium TABLET;ORAL 214803-003 Jan 22, 2021 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Dr Reddys Labs Sa LIOTHYRONINE SODIUM liothyronine sodium TABLET;ORAL 090097-003 Mar 20, 2009 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Biocon Pharma LIOTHYRONINE SODIUM liothyronine sodium TABLET;ORAL 218070-003 Feb 6, 2024 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sigmapharm Labs Llc LIOTHYRONINE SODIUM liothyronine sodium TABLET;ORAL 200295-002 Nov 29, 2012 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

DrugChatter Q&A for LIOTHYRONINE
Inactive ingredients of liothyronine sodium?
Liothyronine brand name?
Buy t3 liothyronine sodium uk?
Liothyronine sodium for sale?
Liothyronine inactive ingredients?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links